Home About Us Services ↳ Canada PR Visa (Permanent Residency) ↳ Work Permit Canada ↳ LMIA — Labour Market Impact Assessment ↳ Spouse & Family Sponsorship Visa ↳ Student Visa Canada ↳ Visitor Visa ↳ Business Visa Provinces ↳ 🏙️ Ontario ↳ 🏔️ British Columbia ↳ 🌾 Alberta ↳ 🌻 Saskatchewan ↳ 🌊 Manitoba ↳ ⚓ Nova Scotia ↳ 🍁 New Brunswick ↳ 🦞 Prince Edward Island ↳ 🐟 Newfoundland & Labrador ↳ 🌊 Atlantic Immigration Program Healthcare Blog FAQ Careers Canadian Latest policies Contact

Change in classification of COVID-19 testing devices: Notice to industry

This notice is to inform manufacturers, importers and distributors of the change in classification of COVID-19 testing devices.

On this page

Background

During the COVID-19 pandemic, SARS-CoV-2 was considered a life-threatening disease with high transmission risk. An accurate diagnosis was critical to reducing public health impacts.

In response, Health Canada:

  • classified all COVID-19 testing devices as Class IV medical devices and
  • authorized a range of COVID-19 testing devices for sale under the Medical Devices Regulations

Since the pandemic, the scientific evidence, risk profile of the disease and public health context have evolved. We have thus re-evaluated the classification of these devices in line with the classification rules in Schedule 1 of the regulations. We have updated the classification to help keep regulatory oversight in proportion to the medical device's risk.

About the classification change

As of March 18, 2026, COVID-19 testing devices are classified as follows:

  • Laboratory-based testing devices: Class II under Schedule 1, Part 2, Rule 2
  • Point-of-care and self-testing devices: Class III under Schedule 1, Part 2, Rule 6

The classification of multiplex testing devices and analyzers that can detect other diseases may also be impacted. The classification of these devices will follow the highest-risk component detected (Schedule 1, Part 2, Rule 7).

The new classification applies to all COVID-19 testing devices currently authorized or licensed for sale under the regulations. This includes multiplex tests and analyzers where applicable.

Implementing the classification change

The new classification does not impact a manufacturer's ability to import and sell their authorized or licensed device.

No action is required from applicants, authorization or licence holders at this time.

We will contact:

  • applicants about their medical device licence application and
  • authorization and licence holders to issue updated authorizations or licences with the new classification

All new applications for medical device licences should reflect the updated classification.

For information on submitting an application, consult:

Contact us

If you have questions about this notice, contact the Medical Devices Directorate at meddevices-instrumentsmed@hc-sc.gc.ca.

Page details

2026-03-18

Quick Enquiry

We usually reply within a few hours
By submitting you agree to be contacted about your enquiry.
Call us Chat on WhatsApp
M

Migova AI Assistant

Online now
Hi 👋 I'm the Migova AI assistant, powered by OpenAI. Ask me about PR, study visas, work permits, LMIA, family sponsorship, provinces, or healthcare immigration to Canada.
Canada PR
Study Visa
LMIA / Work Permit